508 related articles for article (PubMed ID: 23265249)
1. The evolving pharmacotherapy of pulmonary fibrosis.
Lota HK; Wells AU
Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Approach to Adult Fibrotic Lung Diseases.
Adegunsoye A; Strek ME
Chest; 2016 Dec; 150(6):1371-1386. PubMed ID: 27521738
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic pulmonary fibrosis: Recent advances on pharmacological therapy.
Spagnolo P; Maher TM; Richeldi L
Pharmacol Ther; 2015 Aug; 152():18-27. PubMed ID: 25946646
[TBL] [Abstract][Full Text] [Related]
4. Treatment of idiopathic pulmonary fibrosis: a network meta-analysis.
Rochwerg B; Neupane B; Zhang Y; Garcia CC; Raghu G; Richeldi L; Brozek J; Beyene J; Schünemann H
BMC Med; 2016 Feb; 14():18. PubMed ID: 26843176
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Rogliani P; Calzetta L; Cavalli F; Matera MG; Cazzola M
Pulm Pharmacol Ther; 2016 Oct; 40():95-103. PubMed ID: 27481628
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone treatment of idiopathic pulmonary fibrosis.
Azuma A
Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
[TBL] [Abstract][Full Text] [Related]
7. [Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment].
Behr J
Dtsch Med Wochenschr; 2012 Mar; 137(12):601-4. PubMed ID: 22415624
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary fibrosis--a therapeutic dilemma?].
Günther A; Markart P; Eickelberg O; Seeger W
Med Klin (Munich); 2006 Apr; 101(4):308-12. PubMed ID: 16607487
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis.
Hilberg O; Simonsen U; du Bois R; Bendstrup E
Clin Respir J; 2012 Jul; 6(3):131-43. PubMed ID: 22697264
[TBL] [Abstract][Full Text] [Related]
10. [Idiopathic pulmonary fibrosis -- progress in sight].
Kaarteenaho R; Hodgson U; Myllärniemi M
Duodecim; 2011; 127(24):2639-45. PubMed ID: 22320106
[TBL] [Abstract][Full Text] [Related]
11. Update in diffuse parenchymal lung disease, 2013.
Rosas IO; Kaminski N
Am J Respir Crit Care Med; 2015 Feb; 191(3):270-4. PubMed ID: 25635490
[TBL] [Abstract][Full Text] [Related]
12. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
13. Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Walter N; Collard HR; King TE
Proc Am Thorac Soc; 2006 Jun; 3(4):330-8. PubMed ID: 16738197
[TBL] [Abstract][Full Text] [Related]
14. [Interstitial lung disease].
von der Beck D; Günther A; Markart P
Dtsch Med Wochenschr; 2011 Jun; 136(22):1191-3. PubMed ID: 21611927
[TBL] [Abstract][Full Text] [Related]
15. Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.
Covvey JR; Mancl EE
Ann Pharmacother; 2014 Dec; 48(12):1611-9. PubMed ID: 25202034
[TBL] [Abstract][Full Text] [Related]
16. Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.
Canestaro WJ; Forrester SH; Raghu G; Ho L; Devine BE
Chest; 2016 Mar; 149(3):756-66. PubMed ID: 26836914
[TBL] [Abstract][Full Text] [Related]
17. Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.
Oltmanns U; Kahn N; Palmowski K; Träger A; Wenz H; Heussel CP; Schnabel PA; Puderbach M; Wiebel M; Ehlers-Tenenbaum S; Warth A; Herth FJ; Kreuter M
Respiration; 2014; 88(3):199-207. PubMed ID: 25115833
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances and Future Needs in Interstitial Lung Diseases.
Jones MG; Richeldi L
Semin Respir Crit Care Med; 2016 Jun; 37(3):477-84. PubMed ID: 27231869
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis: the turning point is now!
Funke M; Geiser T
Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356
[TBL] [Abstract][Full Text] [Related]
20. Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis.
Nagai S; Hamada K; Shigematsu M; Taniyama M; Yamauchi S; Izumi T
Intern Med; 2002 Dec; 41(12):1118-23. PubMed ID: 12521199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
